119 related articles for article (PubMed ID: 17922414)
1. Analysis of SOX4 gene mutation in non-small cell lung cancer tissues.
Chen QL; Zheng WL; Yao WJ; Nie LW; Cheng SH; Ma WL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):505-9. PubMed ID: 17922414
[TBL] [Abstract][Full Text] [Related]
2. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer.
Medina PP; Castillo SD; Blanco S; Sanz-Garcia M; Largo C; Alvarez S; Yokota J; Gonzalez-Neira A; Benitez J; Clevers HC; Cigudosa JC; Lazo PA; Sanchez-Cespedes M
Hum Mol Genet; 2009 Apr; 18(7):1343-52. PubMed ID: 19153074
[TBL] [Abstract][Full Text] [Related]
3. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
[TBL] [Abstract][Full Text] [Related]
4. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
[TBL] [Abstract][Full Text] [Related]
6. ERBB2 kinase domain mutation in the lung squamous cell carcinoma.
Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH
Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927
[TBL] [Abstract][Full Text] [Related]
7. Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma.
Chen HL; Fan LF; Gao J; Ouyang JP; Zhang YX
Oncol Rep; 2011 Feb; 25(2):359-66. PubMed ID: 21165568
[TBL] [Abstract][Full Text] [Related]
8. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of mutation types of p53 gene and possible carcinogenic factors in lung cancer].
Gao ZQ; Gao Z; Zhang X
Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Mar; 31(2):88-91. PubMed ID: 9812619
[TBL] [Abstract][Full Text] [Related]
11. [Mutations in exon 19 of EGFR gene in non-small cell lung cancer from Chinese patients].
Wang HY; Luo H; Zhao YM; Tang L; Zhou CC
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):315-8. PubMed ID: 18543225
[TBL] [Abstract][Full Text] [Related]
12. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
[TBL] [Abstract][Full Text] [Related]
13. [Development and application of the method for controlling contamination of tumor samples with normal cells to detect deletion of P16 gene in primary lung carcinoma].
Ran R; Cao XA; Tian Y
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):136-40. PubMed ID: 10072815
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers.
Lee SH; Shin MS; Kim HS; Lee HK; Park WS; Kim SY; Lee JH; Han SY; Park JY; Oh RR; Jang JJ; Han JY; Lee JY; Yoo NJ
Cancer Res; 1999 Nov; 59(22):5683-6. PubMed ID: 10582684
[TBL] [Abstract][Full Text] [Related]
15. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
Lou Y; Fang CQ; Li JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
[TBL] [Abstract][Full Text] [Related]
16. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
[TBL] [Abstract][Full Text] [Related]
18. p53 gene mutations in non-small cell lung cancer from Thai patients.
Petmitr S; Makthiengtrong S; Sutinont P; Migasena P
J Med Assoc Thai; 1999 Mar; 82(3):250-5. PubMed ID: 10410479
[TBL] [Abstract][Full Text] [Related]
19. p53AIP1 expression can be a prognostic marker in non-small cell lung cancer.
Yamashita SI; Masuda Y; Yoshida N; Matsuzaki H; Kurizaki T; Haga Y; Ikei S; Miyawaki M; Kawano Y; Chujyo M; Kawahara K
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):148-51. PubMed ID: 17851056
[TBL] [Abstract][Full Text] [Related]
20. [p16INK4/CDKN2 gene deletions and mutations in non-small cell lung cancers].
Wang G; Du C; Lin Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Feb; 15(1):5-8. PubMed ID: 9456359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]